Antares Pharma Inc. (NASDAQ:ATRS) went up by 0.87% during the previous trading session, and it is maintaining the win ahead of Friday’s trading session. The share price of the Medical Instruments & Supplies giant went up by $2.90 to trade ended Friday trading at $2.88. This is up from the $2.875 price recorded on Thursday’s trading session. Thanks to this latest performance, ATRS is closer to the higher price 52-week target of $8.00 and further from the lowest price target of $4.50. Its performance from the start of the year has also been negative, with ATRS down by -38.30% year-to-date.
Antares Pharma Inc. (ATRS) started the day trading at $2.91 and recorded an intraday high of $2.98. It also recorded an intraday low of $2.87 during Friday’s trading session. Antares Pharma Inc. is a very active stock that recorded a trading volume that is more than 32.47% of the average daily trading volume on Friday. The stock’s trading volume on Friday was 2073189, which is more than 32.47 of the total average daily trading volume of 1.40 million.
Antares Pharma Inc. (NASDAQ:ATRS) 2020 Performance Impressive
The increase in ATRS’s stock price on Friday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of ATRS currently stands at $5.13, which is higher than the current trading price of the stock by 43.47%. However, ATRS’s current trading price is -81.25% lower than the 52-week low price of $1.60. In terms of trading volume, Antares Pharma Inc. currently experienced healthy participation during the last trading session. 2073189 shares of Antares Pharma Inc. were traded on the stock exchange on Friday, which is more than 32.47% of the 1.40 million average trading volume of the stock.
The performance of the stock has been positive over the past year. ATRS’s performance over the past one year has seen it plunge by -3.01%, while the stock has gone down by -40.33% in the last six months. The quarterly performance of ATRS currently stands at 64.77%, and it is up by 5.84% in the last month. The only positive figure was from the weekly performance, which currently reads 4.32%. At the time of writing ATRS’s report, the company has a total market cap of $476.01M, making it one of the largest publicly-traded companies in the world.Antares Pharma Inc. also has over 178 employees all over the world.
ATRS Insider Activities
For Antares Pharma Inc., insiders hold 43.10% of all company shares. The insider transactions over the past six months are up by 11.50%. During that period, insiders bought 1,517,796 shares in 18 transactions. In that same period, insiders sold 604,333 of their shares in 17 transactions. After these transactions, insiders at Antares Pharma Inc. now hold 12.34M shares, which is over 41.63% of the total company stocks. Institutional investors currently hold a large chunk of the ATRS shares, as they control 7.45% of the company’s total stock.
ATRS Fundamental Analysis
For Antares Pharma Inc., the stock’s diluted earnings per share (EPS) stands at 0.01. In the coming year, analysts expect the EPS to be 0.24. The stock’s EPS growth this year is 69.90%, 45.90% in the previous five years. In terms of revenue, Antares Pharma Inc.’s quarterly sales (YOY) is shrinking at 0.00, which is lower than the average annual revenue of 45.90% over the past half a decade.
The Return on Investment (ROI) on Antares Pharma Inc.’s stock currently stands at 1.00%, and it has a net profit margin of 0.90%. The operating margin of the company is 3.40%, and its gross margin is 59.20%.
ATRS Analysts Prediction
In October 23, 2017, several analysts reiterated their positions on the Antares Pharma Inc. stock and predicted its performance to their investors. The analysts at H.C. Wainwright believe ATRS is still a Buy and set the price target between $5 and $3.50.
Analysts at Ladenburg Thalmann believe that ATRS is Buy, and they have a price target of between $5 and $5.75.
ATRS Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of ATRS currently stands at 0.25%, while the SMA50 is 1.82%. The biggest one is the SMA200, which is currently reading -16.15% ahead of Friday’s trading session. The Relative Strength Index of this stock is 52.42, while its price to earnings ratio (P/E) is 414.29.